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The effect ofneuropeptide Y iNPY) on cytosolic free CaZf concentration ([Car”],) was studied in cultured smooth muscle cells from porcine aorta 
(PASMC) and compared with the effect of bradykinin (BK) and an~otensin II (ATII) on [Caa’],. All peptides induced ose-dependent a d transient 
rises in [Ca2’], which were not blocked by extracellular EGTA, but the NPY response was different from the others’ as follows. First, the [Ca”], 
rise induced by NPY was not as rapid as that induced by BK or ATII. Second, pertussis toxin abolished the [Ca*+], rise induced by NPY, but 
not by BK or ATE. Third, following initial treatment with BK, PASMC were able to respond to NPY, but not to ATII. Finally, BK and ATII, 
but not NPY, signit%zantly increased inositol 1,4,5+risphosphate (Ins( 1,4,5)P,) generation. Although NPY attenuated forskolin-induced accumula- 
tion of cyclic AMP, forskolin- and 3-isobutyl-1-methyl-xanthine-induced alterations in intracellular cyclic AMP did not affect the NPY-induced 
[Ca2+], rise. These results suggest hat+NPY increases [Caz’]l by a pertussis toxin-sensitive GTP binding protein-involved mechanism which is not 
mediated by the intra~ll~ar messengers such as Ins(1,4,5)P, and cyclic AMP. 
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1. INTRODUCTION 
Neuropeptide Y (NPY) coexists with noradrenaline in 
a population of sympathetic neurons and modulates 
noradrenergic responses [1,2]. Vascular smooth muscle 
is one of such tissues that are under the control of nor- 
adrenaline and NPY [2-51. For example, NPY poten- 
tiates noradrenaline-evoked vasoconstriction post- 
junctionally and suppresses the release of noradrenaline 
from sympathetic nerve endings upon stimulation [3,4]. 
In some isolated blood vessels, in addition, NPY itself 
is known to be a potent vasoconstrictor [1,2,6]. 
mechanism from bradykinin (BK) or angiotensin II 
(ATII). The NPY response seems to involve a pertussis 
toxin-sensitive GTP binding protein and not to be 
mediated by Ins(1,4,5)P3 or cyclic AMP. 
2. MATERIALS AND METHODS 
2. I. Materials 
The transmembrane signalling mechanism of NPY 
action has been demonstrated in neural cells [7-lo]. 
Perney and Miller have found that NPY can stimulate 
the synthesis of inositol trisphosphate (Ins( 1,4,5)P3) 
and increase cytosolic free calcium ([Ca”]i) in cultured 
rat sensory neurons [9]. On the other hand, studies with 
vascular smooth muscle cells have been confined to sug- 
gesting the possibility that inhibition of cyclic AMP ac- 
cumulation is causally related to vasoconstriction 
[11,12]. 
Porcine NPY, BK, and AT11 were purchased from the Peptide 
Institute (Osaka, Japan). Fura-2-AM was obtained from Dojin 
(Kumamoto, Japan). 3-Isobutyl-l-methyl-xanthine (IBMX) and fors- 
kolin were from Sigma. Nisordipine, verapamil and diltiazem were 
donated by Dr Ikuo Adachi of our laboratories. 
2.2. Cell culture 
PASMC were isolated from explants of aortic media as described 
by Ross 1141. Cells were grown in Medium 199 supplemented with 
10% fetal calf serum (Gibco), 10 mM Hepes (pH 7.4) and antibiotics 
in a 5% COr/95% air incubator at 37°C. The cells were subcultured 
at confluency, and only cells in passages 3-8 were used for ex- 
periments. 
2.3. Determination of (Ca’+], 
Since the primary trigger for contraction of smooth 
muscle is thought to be a rise in [Ca’+]i [13], we attemp- 
ted to examine the possible coupling of NPY receptors 
on porcine aortic smooth muscle cells (PASMC) to in- 
tracellular calcium regulating systems. We show here 
that NPY may elevate PASMC [Ca’+]i by a different 
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The cytosolic Ca*+ concentration was fluorometrically measured 
using the Ca’+ -sensitive fluorescent dye fura-2. PASMC were grown 
to reach confluency in 7%cm* flasks and trypsinized (0.05% trypsin 
with 0.2% EDTA, 3 min, 37’C). Cell suspensions were washed once 
with growth medium. The single cells were counted and resuspended 
in Hepes (20 mMf)-buffered Hanks’ solution so that a final concentra- 
tion of 1 x lo6 cells/ml was obtained. The cell suspensions were in- 
cubated with 2rM fura-2-AM at 37°C for 30-60 min. The 
fura-2-loaded cells thus obtained were washed twice and resuspended 
in Hepes (20 mM)-buffered Hanks’. solution (pH 7.4) at 
5 x 10’ cells/ml, and 0.5 ml of the suspension was placed in each 
cuvette. During experiments in the spectrofluorometer (CAF-100, 
Japan Spectroscopy Inc., Tokyo, Japan), the cell suspensions were 
continuously stirred with a small magnetic bar within the cuvettes. Ex- 
~bf~hed by Efsevier Science Publishers B. V. ~3iomedical divisions 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 79 
Volume 259, number 1 FEBS LETTERS December 1989 
citation wavelengths of 340 and 380 nm and an emission wavelength 
of 510 nm were used. [Ca”], was calculated according to the follow- 
ing formula [15] 
[Ca*+l, = K(F - F,,,)/(Fmax - F) 
In this formula, K is the affinity of fura- for Ca’+ ions. We set K = 
224 nM, as previously determined by Grynkiewicz et al. [ 151. F, Fmin, 
and F,,,, are the fluorescence at a time of interest, at zero, and satu- 
rated [Ca*+]i, respectively, after correction for extracellular fura-2. 
Fluorescence dye to extracellular fura- was determined by adding 
100 pM MnClz to the cells at the beginning and the end of each experi- 
ment. The cells were lysed with Triton X-100 followed by the addition 
of EGTA plus Tris to obtain F,,,,, and F,,,, respectively. 
2.4. Measurement of cyclic AMP 
Single cells at 1 x 106/ml were preincubated in a total volume of 
200 /tl Medium 199 containing 10 mM Hepes (pH 7.4) in the presence 
or absence of 0.1 mM IBMX for 10 min at 37”C, and then incubated 
with 1 pM NPY with or without 1OpM forskolin. 40~1 of 50% tri- 
chloroacetic acid was added to stop the incubation. After extracting 
trichloroacetic acid with water-saturated ether, media were subjected 
to radioimmunoassay for cyclic AMP (Amersham). 
2.5. Measurement of inositol1,4,5-trisphosphate (Ins(I,4,5)Pj) 
Ins(l,4,5)Ps was determined using the protein binding assay kit 
(Amersham) as described by Fu et al. [la]. In brief, single cells at 
5 x 106/ml were preincubated in 200~1 Medium 199 containing 
10 mM LiCl and 10 mM Hepes (pH 7.4) for 10 min at 37”C, and then 
incubated with 1 pM NPY, BK, or ATII. At the end of the incuba- 
tion, 37 ,~l of 20% HCl04 was added. After neutralizing the media 
with 13.5-14~1 10 M KOH, supernatants were subjected to 
Ins(l,4,5)P3 assay. 
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3. RESULTS 
The effects of NPY on [Ca’+]i in PASMC are docu- 
mented in fig.1. NPY caused a dose-dependent and 
transient increase in [Ca’+]i, which reached maximal 
level at lo-’ M; the EDso estimated at approximately 
3 x 10e9 M (fig.lA). To study whether the increase in 
[Ca2+]i could come either from intracellular stores or 
from outside the cell, we added 2 mM EGTA to a cell 
suspension to chelate all extracellular Ca2+ 2 min 
before adding NPY (fig. 1B). The treatment only slight- 
ly diminished the increase in [Ca2+]i induced by NPY. 
It was the case with those induced by BK and AT11 
(data not shown). The calcium channel blocker, nisor- 
dipine, did not inhibit the NPY response at all (fig.lB). 
Verapamil and diltiazem had no effect either (results 
not shown). 
PASMC responded to not only NPY, but also to BK 
or ATII, as shown in fig.lC. Once a maximal dose of 
each agonist increased [Ca2+]i in PASMC, the cells did 
not respond to an additional exposure to the same 
agonist (fig.lC). A first stimulation with a maximal 
dose of BK strongly suppressed the [Ca’+]i response to 
a subsequent challenge with a maximal dose of ATII. In 
contrast, after BK challenge, a maximal dose of NPY 
still induced a [Ca2+]i rise. A first stimulation with a 
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Fig.1. NPY-, ATII- and BK-induced increases in [Ca’+]i n PASMC. [Ca2+]i was measured with a fluorescent indicator, fura-2. Calculated values 
of [Ca’+]i are shown on the ordinates. (A) Concentration-response r lationship of NPY-induced Ca ‘+-fura- fluorescence. (B) Effect of pretreat- 
ment of cells with EGTA or nisordipine (NS) for 2 min on the NPY response. (C) Effect of sequential stimulations on the [Ca”], rises induced 
by NPY, AT11 and BK. Cells were stimulated by lo-’ M NPY, 10m6 M ATII, or 10e6 M BK at arrows. (D) Effect of pretreatment of cells with 
pertussis toxin on NPY-, ATII- and BK-induced increases in [Ca”],. Cells were cultured without (i) or with 100 ng/ml pertussis toxin (IAP) (ii) 
for 3 h before preparing fura-2-loaded cell suspensions. Cells were challenged with 10d6 M of each agonist. Dotted lines represent the initial velocity 
of the [Ca”], rises. The traces were obtained from one experiment, but are representative of 3 other experiments. 
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maximal dose of NPY hardly influenced the BK- or 
ATII-response (results not shown). 
As shown in fig.lC and D, the maximal NPY re- 
sponse was always smaller than the maximal BK re- 
sponse, but nearly equal to or a little greater than the 
maximal AT11 response. The [Ca’+]r rise induced by 
NPY occurred after a lag period of a few seconds and 
was not as rapid as those induced by AT11 and BK, as 
shown by the dotted lines in fig.lD. When PASMC 
were pretreated with 100 ng/ml pertussis toxin for 3 h 
and then challenged with the agonists, only the NPY- 
induced increase in [Ca’+]i was prevented (fig.lD). 
Ins(1,4,5)Ps, a product of phosphoinositide hydro- 
lysis, is believed to act as a second messenger mediating 
the release of Ca2+ from intracellular store sites [17]. 
The resting level of Ins(1,4,5)Ps after lo-min incuba- 
tion with 10 mM LiCl was 3.90 f 0.98 pmol/106 cells. 
As shown in fig.2, BK and AT11 induced 220% and 
63% increases above basal levels for 15-s incubation, 
respectively. The potency of BK and AT11 to generate 
Ins(l,4,5)P3 seemed to correlate to that of each peptide 
to induce the [Ca2+]i rise (fig.lC and D). However, 
NPY did not significantly increase Ins(1,4,5)P3 above 
basal levels. 
Next, we investigated the involvement of cyclic AMP 
in the NPY-induced [Ca2+]i rise. NPY did not have any 
effect on the basal cyclic AMP level in PASMC 
(fig.3B). Preincubation with IBMX (0.1 mM) increased 
the cyclic AMP level in PASMC by 16-fold, but it had 
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Fig.2. Effect of NPY, AT11 and BK on Ins(l,4,5)P3 generation in 
PASMC. Cell suspensions were preincubated in medium for 10 min, 
and then stimulated by NPY (M), AT11 (ti) or BK (D----O) 
(10e6 M each) for the indicated times. Values are the mean + SE for 
4 determinations. *P<O.l and **P<O.Ol compared to the basal 
level. 
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Fig.3. No implication of cyclic AMP in the NPY-induced [Ca”], rise. 
(A) Effect of forskolin and IBMX on NPY-induced increase in 
[Ca”],. Forskolin (10 pM, FK) was added simultaneously with NPY 
(10m6 M) and IBMX (0.1 mM) was added 10 min before NPY 
(10m6 M). Details as described in fig. 1. (B) Effect of NPY stimulation 
on the cyclic AMP level in PASMC. (Left) Control (G---O) or 
IBMX-preincubated PASMC (+--o) were incubated with 10m6 M 
NPY. (Right) Incubations were initiated with the addition of 10 CM 
forskolin with (O--O) or without 10e6 M NPY (C--G). Cyclic 
AMP content was determined as described in section 2. Values are the 
mean + SE for 3 determinations. 
no effect on the NPY-induced [Ca’+]i rise (fig.3). Fur- 
thermore, forskolin had no effect on resting [Ca’+]i and 
NPY-induced [Ca2+]i rise, whereas NPY significantly 
suppressed forskolin-induced accumulation of cyclic 
AMP, as described by others [11,12] (fig.3). 
4. DISCUSSION 
Reynolds and Yokota have demonstrated that NPY 
did not stimulate phosphoinositide hydrolysis or the 
elevation of [Ca’+]r in cultured smooth muscle cells 
from rabbit pulmonary artery [ 121. In PASMC, in con- 
trast, NPY dose-dependently caused a rapid and tran- 
sient [Ca’+]i rise. Increases in [Ca2+]i n the smooth 
muscle cells are induced from two main sources; one is 
influx of extracellular Ca2+ and the other is release of 
Ca2+ from store sites. The NPY-stimulated increase in 
[Ca’+]i was only slightly diminished by extracellular ex- 
cess EGTA and was not affected by voltage-dependent 
Ca2+ channel blockers. Therefore, the main source of 
NPY-induced Ca2+ mobilization seems to be the intra- 
cellular Ca2+ storage site. Besides, NPY may induce a 
small influx of Ca2+ via the receptor-operated Ca2+ 
channel. Alternatively, apparent partial dependency of 
the NPY response upon extracellular Ca’+ may be 
because EGTA may facilitate the leak of Ca’+ from 
cells leading to the decrease in the intracellular Ca2+ 
81 
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stores or because replenishment of the intracellular 
Ca2+ pool following agonist-induced emptying of the 
pool is partially due to a pathway from the extracellular 
space to the pool [18]. 
Although ATII- and BK-induced increases in [Ca2+]i 
were mainly dependent upon intracellular Ca2+ storage 
in the same way as the NPY response, some differences 
were observed between NPY- and the other peptide- 
induced [Ca2’]i rises. First, the [Ca2+]i rise induced by 
NPY was not as rapid as that induced by BK or ATII. 
Second, pertussis toxin abolished the [Ca’+]i rise in- 
duced by NPY, but not by BK or ATII. Third, follow- 
ing initial treatment with BK, PASMC were able to re- 
spond to NPY, but not to ATII. Finally, BK and ATII, 
but not NPY, significantly increased Ins( 1,4,5)P3 
generation. These results suggest hat NPY increases 
[Ca’+]i in PASMC by a pertussis toxin-sensitive GTP 
binding protein-involved and Ins(l,4,5)P3_independent 
signal-transducing system, whereas the effects of AT11 
and BK are at least partially common, as judged from 
their hetero-desensitization (fig.lC), and possibly 
mediated through the elevation of Ins(1,4,5)P3 which 
releases Ca2+ from intracellular store sites, as described 
previously [ 19,201. The reason the NPY response is not 
as rapid as the BK or AT11 response is not clear at pre- 
sent, but must be closely related to the mechanism of 
NPY action. 
IBMX- and forskolin-induced changes in intra- 
cellular cyclic AMP did not have any effect on the 
NPY-induced [Ca2+]i rise, although NPY attenuated 
the forskolin-induced accumulation of cyclic AMP 
(fig.3). These results indicate that the Ca2+ mobiliza- 
tion is not secondary to inhibition of adenylate cyclase. 
Activation of many types of receptors mobilizes Ca2+ 
through generation of Ins(1,4,5)P3 [17]. In rat dorsal 
root ganglion neurons, NPY stimulates Ins( 1,4,5)P3 
generation leading to an increase in [Ca2+]i through a 
pertussis toxin-sensitive GTP binding protein [B-lo]. 
There may be the possibility that NPY mobilizes Ca2+ 
in PASMC by tiny amounts of Ins( 1,4,5)P3 that could 
not be detected in our assay. However, we rule out this 
possibility because NPY gave rise to the [Ca”]i rise 
which was similar to or more than that induced by 
ATII, which substantially stimulated Ins(l,4,5)P3 
generation. Motulsky and Michel have demonstrated 
that NPY increases [Ca2+]i n a manner that does not 
appear to involve Ca2+ influx or Ins( 1,4,5)P3 genera- 
tion in human erythroleukemia cells [21]. At present, 
the mechanism of NPY-induced Ca2+ mobilization in 
PASMC also remains obscure. NPY receptors may be 
linked to the generation of an as yet unknown 
messenger leading to mobilization of Ca2+. Alternative- 
ly, like receptors for glucagon, insulin and oxytocin 
[22-241, they may be negatively linked to the plasma 
membrane-Ca2+ pump (Ca2+-ATPase) leading to an in- 
crease in [Ca2+]i. 
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